Tag: antimicrobial resistance
Pfizer transforms Melbourne facility into cutting-edge pharmaceutical manufacturing hub
Pfizer Australia is investing AUD 150 million to upgrade its Melbourne facility into one of the country’s most advanced pharmaceutical production sites to combat antimicrobial resistance (AMR).
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
